Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Brett Case

Showing results (41-50 of 87) with videos related to

Pageof 9
Sort By:
Cell|March 10, 2021
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protectionEmma S Winkler, Pavlo Gilchuk, Jinsheng Yu, et al.
Cell Host & Microbe|August 18, 2020
Replication-Competent Vesicular Stomatitis Virus Vaccine Vector Protects against SARS-CoV-2-Mediated Pathogenesis in MiceJames Brett Case, Paul W Rothlauf, Rita E Chen, et al.
The Journal of Clinical Investigation|April 26, 2022
An antibody targeting the N-terminal domain of SARS-CoV-2 disrupts the spike trimerNaveenchandra Suryadevara, Andrea R Shiakolas, Laura A VanBlargan, et al.
Biorxiv : the Preprint Server for Biology|February 24, 2025
Short 5' UTRs serve as a marker for viral mRNA translation inhibition by the IFIT2-IFIT3 antiviral complexDustin R Glasner, Candace Todd, Brian Cook, et al.
Nature|May 19, 2020
Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibodyDora Pinto, Young-Jun Park, Martina Beltramello, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Structural and functional analysis of a potent sarbecovirus neutralizing antibodyDora Pinto, Young-Jun Park, Martina Beltramello, et al.
Nature|May 15, 2024
Imprinting of serum neutralizing antibodies by Wuhan-1 mRNA vaccinesChieh-Yu Liang, Saravanan Raju, Zhuoming Liu, et al.
Nature|June 28, 2021
SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responsesJackson S Turner, Jane A O'Halloran, Elizaveta Kalaidina, et al.
Nature Structural & Molecular Biology|April 28, 2026
TMPRSS2-mediated coronavirus spike activation and inhibitionMatthew McCallum, James Brett Case, Jack T Brown, et al.
Cell|June 20, 2020
A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing AntibodiesAhmed O Hassan, James Brett Case, Emma S Winkler, et al.
Pageof 9

Showing results (41-50 of 87) with videos related to

Sort By:
Pageof 9
Cell|March 10, 2021
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protectionEmma S Winkler, Pavlo Gilchuk, Jinsheng Yu, et al.
Cell Host & Microbe|August 18, 2020
Replication-Competent Vesicular Stomatitis Virus Vaccine Vector Protects against SARS-CoV-2-Mediated Pathogenesis in MiceJames Brett Case, Paul W Rothlauf, Rita E Chen, et al.
The Journal of Clinical Investigation|April 26, 2022
An antibody targeting the N-terminal domain of SARS-CoV-2 disrupts the spike trimerNaveenchandra Suryadevara, Andrea R Shiakolas, Laura A VanBlargan, et al.
Biorxiv : the Preprint Server for Biology|February 24, 2025
Short 5' UTRs serve as a marker for viral mRNA translation inhibition by the IFIT2-IFIT3 antiviral complexDustin R Glasner, Candace Todd, Brian Cook, et al.
Nature|May 19, 2020
Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibodyDora Pinto, Young-Jun Park, Martina Beltramello, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Structural and functional analysis of a potent sarbecovirus neutralizing antibodyDora Pinto, Young-Jun Park, Martina Beltramello, et al.
Nature|May 15, 2024
Imprinting of serum neutralizing antibodies by Wuhan-1 mRNA vaccinesChieh-Yu Liang, Saravanan Raju, Zhuoming Liu, et al.
Nature|June 28, 2021
SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responsesJackson S Turner, Jane A O'Halloran, Elizaveta Kalaidina, et al.
Nature Structural & Molecular Biology|April 28, 2026
TMPRSS2-mediated coronavirus spike activation and inhibitionMatthew McCallum, James Brett Case, Jack T Brown, et al.
Cell|June 20, 2020
A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing AntibodiesAhmed O Hassan, James Brett Case, Emma S Winkler, et al.
Pageof 9